Headache in patients with systemic lupus erythematosus: A matched case-control study.

IF 5.4 2区 医学 Q1 CLINICAL NEUROLOGY Headache Pub Date : 2025-02-28 DOI:10.1111/head.14919
Igor de Oliveira, Bruno Rodrigo de Fontes, Henrique de Ataíde Mariz, Angela Luzia Branco Pinto Duarte, Pedro Augusto Sampaio Rocha-Filho
{"title":"Headache in patients with systemic lupus erythematosus: A matched case-control study.","authors":"Igor de Oliveira, Bruno Rodrigo de Fontes, Henrique de Ataíde Mariz, Angela Luzia Branco Pinto Duarte, Pedro Augusto Sampaio Rocha-Filho","doi":"10.1111/head.14919","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To compare the prevalence and characteristics of headaches between patients with systemic lupus erythematosus (SLE) and people without the disease and to assess whether there was a relationship between headaches and disease activity.</p><p><strong>Background: </strong>Headache is a common symptom in patients with SLE; however, the effect of SLE on headaches is not fully known.</p><p><strong>Methods: </strong>This was a case-control study. Individuals with and without SLE matched by age and sex were compared. All participants were assessed by a neurologist. A semi-structured questionnaire, the six-item Headache Impact Test (HIT-6) and the Hospital Anxiety and Depression Scale were used. Disease activity was measured by a rheumatologist using the Physician Global Assessment (PGA) and quantified using the modified Systemic Lupus Erythematosus Disease Activity Index 2000 scale (modified SLEDAI-2K). Data were collected between November 2021 and January 2023.</p><p><strong>Results: </strong>A total of 228 individuals were included, 114 in each group. The SLE group presented with more moderate/severe headache attacks than the controls (odds ratio [OR] 2.45, 95% confidence interval [CI] 1.21-4.95; p = 0.013). When comparing patients with active SLE and those without disease activity, there was no difference in the prevalence (OR 1.48, 95% CI 0.38-5.74), type (migraine: OR 1.69, 95% CI 0.71-3.99; tension-type headache: OR 0.64, 95% CI 0.25-1.68), frequency (4; 2-15 vs. 3; 1-12 days/month; p = 0.250), intensity (moderate/severe intensity: OR 0.59, 95% CI 0.19-1.82), or impact of headache (HIT-6: 61; 50-65 vs. 56; 45-63; p = 0.278). The magnitude of SLE activity (modified SLEDAI-2K) demonstrated no statistically significant association with the impact (standardized beta coefficient: 0.02, 95% CI -0.05 to 0.09; p = 0.792) or monthly frequency of headache (standardized beta coefficient: 0.09, 95% CI -0.08 to 0.26; p = 0.275).</p><p><strong>Conclusions: </strong>Headache is a common symptom in SLE, although the prevalence was similar to that of the controls without the disease. While patients with SLE had more intense headache attacks than the controls without SLE, there was no association between headache and SLE activity.</p>","PeriodicalId":12844,"journal":{"name":"Headache","volume":" ","pages":""},"PeriodicalIF":5.4000,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Headache","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/head.14919","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: To compare the prevalence and characteristics of headaches between patients with systemic lupus erythematosus (SLE) and people without the disease and to assess whether there was a relationship between headaches and disease activity.

Background: Headache is a common symptom in patients with SLE; however, the effect of SLE on headaches is not fully known.

Methods: This was a case-control study. Individuals with and without SLE matched by age and sex were compared. All participants were assessed by a neurologist. A semi-structured questionnaire, the six-item Headache Impact Test (HIT-6) and the Hospital Anxiety and Depression Scale were used. Disease activity was measured by a rheumatologist using the Physician Global Assessment (PGA) and quantified using the modified Systemic Lupus Erythematosus Disease Activity Index 2000 scale (modified SLEDAI-2K). Data were collected between November 2021 and January 2023.

Results: A total of 228 individuals were included, 114 in each group. The SLE group presented with more moderate/severe headache attacks than the controls (odds ratio [OR] 2.45, 95% confidence interval [CI] 1.21-4.95; p = 0.013). When comparing patients with active SLE and those without disease activity, there was no difference in the prevalence (OR 1.48, 95% CI 0.38-5.74), type (migraine: OR 1.69, 95% CI 0.71-3.99; tension-type headache: OR 0.64, 95% CI 0.25-1.68), frequency (4; 2-15 vs. 3; 1-12 days/month; p = 0.250), intensity (moderate/severe intensity: OR 0.59, 95% CI 0.19-1.82), or impact of headache (HIT-6: 61; 50-65 vs. 56; 45-63; p = 0.278). The magnitude of SLE activity (modified SLEDAI-2K) demonstrated no statistically significant association with the impact (standardized beta coefficient: 0.02, 95% CI -0.05 to 0.09; p = 0.792) or monthly frequency of headache (standardized beta coefficient: 0.09, 95% CI -0.08 to 0.26; p = 0.275).

Conclusions: Headache is a common symptom in SLE, although the prevalence was similar to that of the controls without the disease. While patients with SLE had more intense headache attacks than the controls without SLE, there was no association between headache and SLE activity.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
目的背景:比较系统性红斑狼疮(SLE)患者和非SLE患者头痛的发生率和特征,并评估头痛与疾病活动之间是否存在关系:背景:头痛是系统性红斑狼疮患者的常见症状;然而,系统性红斑狼疮对头痛的影响尚不完全清楚:这是一项病例对照研究。方法:这是一项病例对照研究,将患有系统性红斑狼疮和未患有系统性红斑狼疮的患者按年龄和性别进行比较。所有参与者都接受了神经科医生的评估。研究中使用了半结构化问卷、六项头痛影响测试(HIT-6)和医院焦虑抑郁量表。疾病活动度由风湿病学家使用医生总体评估(PGA)进行测量,并使用改良的系统性红斑狼疮疾病活动度指数2000量表(改良的SLEDAI-2K)进行量化。数据收集时间为 2021 年 11 月至 2023 年 1 月:共纳入 228 人,每组 114 人。系统性红斑狼疮组的中度/重度头痛发作次数多于对照组(几率比 [OR] 2.45,95% 置信区间 [CI] 1.21-4.95;P = 0.013)。如果将活动性系统性红斑狼疮患者与无疾病活动的患者进行比较,两者在发病率(OR 1.48,95% CI 0.38-5.74)、类型(偏头痛:OR 1.69,95% CI 0.38-5.74)和发作频率(OR 1.48,95% CI 0.38-5.74)方面没有差异:偏头痛:OR 1.69,95% CI 0.71-3.99;紧张型头痛:OR 0.64,95% CI 0.71-3.99:OR 0.64,95% CI 0.25-1.68)、频率(4;2-15 vs. 3;1-12 天/月;P = 0.250)、强度(中度/重度:OR 0.59,95% CI 0.19-1.82)或头痛的影响(HIT-6:61;50-65 vs. 56;45-63;P = 0.278)。系统性红斑狼疮活动程度(改良的 SLEDAI-2K)与头痛的影响(标准化贝塔系数:0.02,95% CI -0.05至0.09;p = 0.792)或每月头痛频率(标准化贝塔系数:0.09,95% CI -0.08至0.26;p = 0.275)无统计学意义:结论:头痛是系统性红斑狼疮的一种常见症状,尽管其发病率与非患者的对照组相似。虽然系统性红斑狼疮患者的头痛发作比非系统性红斑狼疮对照组患者更剧烈,但头痛与系统性红斑狼疮的活动性之间并无关联。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Headache
Headache 医学-临床神经学
CiteScore
9.40
自引率
10.00%
发文量
172
审稿时长
3-8 weeks
期刊介绍: Headache publishes original articles on all aspects of head and face pain including communications on clinical and basic research, diagnosis and management, epidemiology, genetics, and pathophysiology of primary and secondary headaches, cranial neuralgias, and pains referred to the head and face. Monthly issues feature case reports, short communications, review articles, letters to the editor, and news items regarding AHS plus medicolegal and socioeconomic aspects of head pain. This is the official journal of the American Headache Society.
期刊最新文献
Serum levels of autotaxin reveal its role as a novel biomarker of migraine. Effect of erenumab versus other migraine preventive medications on cardiovascular and cerebrovascular outcomes: A United States claims database-based observational cohort study. The impact of headache intensity on speech in participants with migraine and acute post-traumatic headache. Cognitive symptoms in veterans with migraine or traumatic brain injury: A Million Veteran Program study. Effects of fremanezumab on migraine-associated symptoms and medication use in Japanese and Korean patients with episodic migraine: Exploratory endpoint analysis of a multicenter, randomized, double-blind, placebo-controlled trial.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1